Krystal Biotech (KRYS) Shares Outstanding (2017 - 2026)

Krystal Biotech's Shares Outstanding history runs 10 years deep, the most recent figure standing at $29.4 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 1.86% year-over-year to $29.4 million; the TTM figure through Mar 2026 stood at $29.4 million (up 1.86% YoY), while the FY2025 annual figure was $29.2 million, up 1.38% from the prior year.
• Shares Outstanding came in at $29.4 million for Q1 2026 at Krystal Biotech, up from $29.2 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $29.4 million in Q1 2026 to a low of $25.2 million in Q1 2022.
• A 5-year average of $27.8 million and a median of $28.5 million in 2024 frame the typical range for Shares Outstanding.
• Across the five-year window, Shares Outstanding advanced 15.61% in 2022 and advanced 0.76% in 2025, its largest moves.
• Krystal Biotech's Shares Outstanding stood at $25.8 million in 2022, then climbed by 9.6% to $28.2 million in 2023, then advanced by 1.97% to $28.8 million in 2024, then climbed by 1.38% to $29.2 million in 2025, then rose by 0.84% to $29.4 million in 2026.
• According to Business Quant data, Shares Outstanding over the past three periods registered $29.4 million, $29.2 million, and $29.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison